Immunome (IMNM) Leases: 2023-2025
Historic Leases for Immunome (IMNM) over the last 3 years, with Sep 2025 value amounting to $3.1 million.
- Immunome's Leases rose 30.86% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 30.86%. This contributed to the annual value of $4.3 million for FY2024, which is 173.53% up from last year.
- According to the latest figures from Q3 2025, Immunome's Leases is $3.1 million, which was down 4.41% from $3.3 million recorded in Q2 2025.
- Immunome's 5-year Leases high stood at $4.3 million for Q4 2024, and its period low was $174,000 during Q2 2023.
- Over the past 3 years, Immunome's median Leases value was $2.4 million (recorded in 2024), while the average stood at $2.3 million.
- Examining YoY changes over the last 5 years, Immunome's Leases showed a top increase of 1,350.00% in 2024 and a maximum decrease of 6.78% in 2024.
- Over the past 3 years, Immunome's Leases (Quarterly) stood at $1.6 million in 2023, then surged by 173.53% to $4.3 million in 2024, then spiked by 30.86% to $3.1 million in 2025.
- Its Leases was $3.1 million in Q3 2025, compared to $3.3 million in Q2 2025 and $4.2 million in Q1 2025.